Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Glucuronolactone Market by Type (Powder, Liquid, Tablet/Capsule), by Application (Preservatives, Antioxidants, Processing Aids and Additives, Energy Supplements), by End User (Food and Beverages, Pharmaceuticals): Global Opportunity Analysis and Industry Forecast, 2023-2032

A13550

Pages: 300

Charts: 53

Tables: 109

Glucuronolactone Market Research, 2032

The global glucuronolactone market was valued at $380.3 million in 2022, and is projected to reach $617.3 million by 2032, growing at a CAGR of 5.2% from 2023 to 2032. Glucuronolactone is a detoxicant and one of the key precursors for the production of vitamin C. It also interacts with toxins in the body to form water-soluble compounds that are excreted via bodily fluids. When combined with other substances, glucuronolactone has been shown to have health benefits on the human body, such as boosting concentration and raising activity levels.

[COVIDIMPACTSTATEMENT]

Glucuronolactone is frequently used in nutrition supplemental food (health and fitness supplements) in the form of powders and capsules to boost strength during exercise sessions and strength training. It’s also found in skin care and safety goods, as well as personal care and medical products. Glucuronolactone is used to make drugs that are used to treat hepatocirrhosis, arthritis, and hepatitis, among other conditions. Animal and poultry feed also contains D-glucuronolactone.

Increased health awareness, evolving consumer lifestyles, changing consumer behaviour for embracing new products, and a rise in demand for convenience foods have all contributed to an increase in demand for dietary supplements globally. Glucuronolactone is often utilized in energy drinks due to its benefits on the human body, such as enhancing physical performance while also facilitating regeneration and rebound after activity. Energy drinks provide a fast burst of energy to the body. Energy drinks commonly include amino acids, carbohydrates, vitamin B, caffeine, and glucuronolactone. The popularity of these functional beverages has skyrocketed in recent years. A variety of factors have led to the growth in demand for power beverages, including changing customer behaviour in terms of product acceptability and increased need for ready meals. As a result of growing urbanisation, consumer tastes have altered, with a demand for things that provide an immediate energy boost. Another important element driving demand for convenience foods and beverages is the rise in disposable income in developed countries. Demand will grow owing to the thriving healthcare and pharmaceutical sectors, since it is extensively utilized in joint therapy to improve muscular performance. Increased health consciousness as a result of internet usage, as well as a shift in customer purchasing behaviour toward energy drinks are factors projected to drive the Glucuronolactone Market Growth during the forecast period.

One factor hindering the Glucuronolactone market demand  is the detrimental health effects of glucuronolactone in the long run. Moreover, the market expansion is hindered by the high cost of nutritional supplements and the diverse adverse reactions they induce. The primary issue regarding energy drinks is the requirement for extra security precautions. The additives in drinks (such as taurine, ginseng, and guarana) have yet to be well-studied and must be carefully regulated by the FDA (food and drug administration). Additionally, companies that make energy drinks may refer to their goods as "supplements" in order to get around laws that apply to other drinking options. Thus, these factors are restraining the market growth.

Rising health consciousness, changes in consumer lifestyle, and increased knowledge of health and wellness products are all contributing to market growth. Growing living standards and an increase in the demand for alcoholic energy drinks are predicted to drive market expansion throughout the projection period. Additionally, the growing demand and popularity of healthcare drinks and supplements in athletes, sportsmen, and gym professionals are driving the growth of the market. Furthermore, high usage of chemicals or metabolites in food and drug along with the adjuvant drugs for the treatment of rheumatoid arthritis will further drive the market growth.

The key players profiled in this report include Anhui Fubore Pharmaceutical & Chemical Co.Ltd., Hubei Yitai Pharmaceutical Co.Ltd., Shandong Fuyuan Bio-Tech CO.LTD., Shandong Baisheng Biotechnology Co., Ltd., Functional Food chem International Corporation, Shaoxing Marina Biotechnology Co.Ltd., Merck Millipore Corporation, Jungbunzlauer, Shandong Xinhong Pharmaceutical Co., Ltd., Roquette Frères. Investment and agreement are common strategies followed by major market players. For instance, On 2 August 2022, PepsiCo invested USD 550 million in Celsius as part of a goal to enhance its focus on the energy category and capitalize on an opportunity to collaboratively boost industry development and innovation. A long-term strategic distribution collaboration has also been created between the two companies, with PepsiCo taking over US distribution and upgrading to the position of preferred partner globally.

The glucuronolactone market segmentation on the basis of type, application, end use, and region. By type, the market is sub-segmented into powder, liquid, and tablet/capsule. By application, the market is classified into preservatives, antioxidants, processing aids & additives, energy supplements, and others. By end user, the market is classified into food & beverages, pharmaceuticals, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The glucuronolactone market is segmented into Type, Application and End User.

[TYPEGRAPH]

By type, the liquid sub-segment dominated the market in 2022. The liquid segment of the glucuronolactone market is being propelled by several driving factors. Its convenience and faster absorption in liquid form enhance consumer preference. The rising demand for energy and sports drinks, where glucuronolactone is commonly included, fuels the market growth. Additionally, the formulation's suitability for various applications such as beverages and functional shots further boosts its adoption. As health and wellness trends persist, and consumers seek convenient and effective solutions, the liquid glucuronolactone market is poised to experience sustained expansion. These are predicted to be the major factors affecting the glucuronolactone market size during the forecast period too.

[APPLICATIONGRAPH]

By application, the antioxidants sub-segment dominated the global glucuronolactone market share in 2022. The antioxidants segment within the glucuronolactone market is being propelled by escalating consumer awareness regarding the health benefits of antioxidants. These compounds aid in neutralizing harmful free radicals, mitigating oxidative stress, and supporting overall well-being. As individuals prioritize preventive healthcare measures, demand for antioxidant-rich products, including those containing glucuronolactone, has surged. Scientific research highlighting the potential for reducing chronic diseases and promoting longevity further amplifies this trend. Consequently, the antioxidants segment is experiencing growth due to the compelling link between glucuronolactone and its potential to contribute to a healthier lifestyle through its antioxidant properties.

[ENDUSERGRAPH]

By end use, the pharmaceuticals sub-segment dominated the global glucuronolactone market share in 2022. The pharmaceutical segment of the glucuronolactone market is being driven by several key factors. Glucuronolactone's potential as a precursor in drug metabolism, aiding detoxification and supporting liver health, has spurred pharmaceutical research and development. Its inclusion in formulations targeting fatigue, cognition, and neurological disorders further propels its demand. Additionally, the growing consumer inclination towards natural and plant-based ingredients aligns with glucuronolactone's origin from glucose metabolism. These factors, coupled with its potential therapeutic benefits, are fueling the integration of glucuronolactone into pharmaceutical products, driving the Glucuronolactone Market Forecast.

[REGIONGRAPH]

By region, North America dominated the global glucuronolactone market in 2022. The increasing population, along with a deskbound working lifestyle, is propelling market expansion in this region. Furthermore, higher food consumption and increased knowledge of the health advantages of antioxidants are boosting market expansion in this region. Due to China's significant product availability, Asia Pacific is expected to grow at the fastest rate throughout the projection period. Furthermore, government assistance, increased investment in R&D, and changing consumer lifestyles are projected to boost market expansion in this region. Apart from that, changing demographics, consumer tastes and drinking habits, and increased health consciousness are expected to boost market expansion throughout the forecast period.

Impact of COVID-19 on the Global Glucuronolactone Industry

  • The COVID-19 pandemic has had a significant impact on the glucuronolactone market. The global glucuronolactone market experienced supply chain disruptions due to lockdowns, travel restrictions, and reduced workforce, affecting the availability of raw materials and ingredients.
  • Manufacturing facilities faced closures and reduced capacity, leading to production slowdowns and potential shortages of glucuronolactone-containing products. Increased focus on health and wellness during the pandemic influenced consumer demand for dietary supplements, impacting the demand for products containing glucuronolactone.
  • Online sales channels, which gained prominence during the pandemic, are likely to remain a crucial distribution channel for glucuronolactone-containing products as consumers continue to value convenience and safety in their purchasing habits.
  • The post-COVID-19 impact might vary across regions based on vaccination rates, economic recovery, and regulatory changes, influencing the pace of market rebound.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the glucuronolactone market analysis from 2022 to 2032 to identify the prevailing glucuronolactone market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the glucuronolactone market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global glucuronolactone market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

  • By Type
    • Powder
    • Liquid
    • Tablet/Capsule
  • By Application
    • Preservatives
    • Antioxidants
    • Processing Aids and Additives
    • Energy Supplements
  • By End User
    • Food and Beverages
    • Pharmaceuticals
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • United Arab Emirates
      • South Africa
      • Rest of LAMEA


Key Market Players

  • Merck Millipore Corporation
  • Shandong Fuyuan Bio-Tech CO.LTD.
  • Shaoxing Marina Biotechnology Co.Ltd.
  • Anhui Fubore Pharmaceutical & Chemical Co.Ltd.
  • Roquette Freres
  • Jungbunzlauer
  • Shandong Baisheng Biotechnology Co., Ltd.
  • Hubei Yitai Pharmaceutical Co.Ltd.
  • Functional Food chem International Corporation
  • Shandong Xinhong Pharmaceutical Co., Ltd.
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report description

    • 1.2. Key market segments

    • 1.3. Key benefits to the stakeholders

    • 1.4. Research Methodology

      • 1.4.1. Primary research

      • 1.4.2. Secondary research

      • 1.4.3. Analyst tools and models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET OVERVIEW

    • 3.1. Market definition and scope

    • 3.2. Key findings

      • 3.2.1. Top impacting factors

      • 3.2.2. Top investment pockets

    • 3.3. Porter’s five forces analysis

    • 3.4. Market dynamics

      • 3.4.1. Drivers

      • 3.4.2. Restraints

      • 3.4.3. Opportunities

    • 3.5. Average Selling Price

    • 3.6. Market Share Analysis

    • 3.7. Brand Share Analysis

    • 3.8. Trade Data Analysis

    • 3.9. Product Consumption

    • 3.10. Value Chain Analysis

    • 3.11. Regulatory Guidelines

    • 3.12. Key Regulation Analysis

    • 3.13. Reimbursement Scenario

    • 3.14. Patent Landscape

  • CHAPTER 4: GLUCURONOLACTONE MARKET, BY TYPE

    • 4.1. Overview

      • 4.1.1. Market size and forecast

    • 4.2. Powder

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast, by region

      • 4.2.3. Market share analysis by country

    • 4.3. Liquid

      • 4.3.1. Key market trends, growth factors and opportunities

      • 4.3.2. Market size and forecast, by region

      • 4.3.3. Market share analysis by country

    • 4.4. Tablet/Capsule

      • 4.4.1. Key market trends, growth factors and opportunities

      • 4.4.2. Market size and forecast, by region

      • 4.4.3. Market share analysis by country

  • CHAPTER 5: GLUCURONOLACTONE MARKET, BY APPLICATION

    • 5.1. Overview

      • 5.1.1. Market size and forecast

    • 5.2. Preservatives

      • 5.2.1. Key market trends, growth factors and opportunities

      • 5.2.2. Market size and forecast, by region

      • 5.2.3. Market share analysis by country

    • 5.3. Antioxidants

      • 5.3.1. Key market trends, growth factors and opportunities

      • 5.3.2. Market size and forecast, by region

      • 5.3.3. Market share analysis by country

    • 5.4. Processing Aids and Additives

      • 5.4.1. Key market trends, growth factors and opportunities

      • 5.4.2. Market size and forecast, by region

      • 5.4.3. Market share analysis by country

    • 5.5. Energy Supplements

      • 5.5.1. Key market trends, growth factors and opportunities

      • 5.5.2. Market size and forecast, by region

      • 5.5.3. Market share analysis by country

  • CHAPTER 6: GLUCURONOLACTONE MARKET, BY END USER

    • 6.1. Overview

      • 6.1.1. Market size and forecast

    • 6.2. Food and Beverages

      • 6.2.1. Key market trends, growth factors and opportunities

      • 6.2.2. Market size and forecast, by region

      • 6.2.3. Market share analysis by country

    • 6.3. Pharmaceuticals

      • 6.3.1. Key market trends, growth factors and opportunities

      • 6.3.2. Market size and forecast, by region

      • 6.3.3. Market share analysis by country

  • CHAPTER 7: GLUCURONOLACTONE MARKET, BY REGION

    • 7.1. Overview

      • 7.1.1. Market size and forecast By Region

    • 7.2. North America

      • 7.2.1. Key market trends, growth factors and opportunities

      • 7.2.2. Market size and forecast, by Type

      • 7.2.3. Market size and forecast, by Application

      • 7.2.4. Market size and forecast, by End User

      • 7.2.5. Market size and forecast, by country

        • 7.2.5.1. U.S.
          • 7.2.5.1.1. Market size and forecast, by Type
          • 7.2.5.1.2. Market size and forecast, by Application
          • 7.2.5.1.3. Market size and forecast, by End User
        • 7.2.5.2. Canada
          • 7.2.5.2.1. Market size and forecast, by Type
          • 7.2.5.2.2. Market size and forecast, by Application
          • 7.2.5.2.3. Market size and forecast, by End User
        • 7.2.5.3. Mexico
          • 7.2.5.3.1. Market size and forecast, by Type
          • 7.2.5.3.2. Market size and forecast, by Application
          • 7.2.5.3.3. Market size and forecast, by End User
    • 7.3. Europe

      • 7.3.1. Key market trends, growth factors and opportunities

      • 7.3.2. Market size and forecast, by Type

      • 7.3.3. Market size and forecast, by Application

      • 7.3.4. Market size and forecast, by End User

      • 7.3.5. Market size and forecast, by country

        • 7.3.5.1. Germany
          • 7.3.5.1.1. Market size and forecast, by Type
          • 7.3.5.1.2. Market size and forecast, by Application
          • 7.3.5.1.3. Market size and forecast, by End User
        • 7.3.5.2. UK
          • 7.3.5.2.1. Market size and forecast, by Type
          • 7.3.5.2.2. Market size and forecast, by Application
          • 7.3.5.2.3. Market size and forecast, by End User
        • 7.3.5.3. France
          • 7.3.5.3.1. Market size and forecast, by Type
          • 7.3.5.3.2. Market size and forecast, by Application
          • 7.3.5.3.3. Market size and forecast, by End User
        • 7.3.5.4. Spain
          • 7.3.5.4.1. Market size and forecast, by Type
          • 7.3.5.4.2. Market size and forecast, by Application
          • 7.3.5.4.3. Market size and forecast, by End User
        • 7.3.5.5. Italy
          • 7.3.5.5.1. Market size and forecast, by Type
          • 7.3.5.5.2. Market size and forecast, by Application
          • 7.3.5.5.3. Market size and forecast, by End User
        • 7.3.5.6. Rest of Europe
          • 7.3.5.6.1. Market size and forecast, by Type
          • 7.3.5.6.2. Market size and forecast, by Application
          • 7.3.5.6.3. Market size and forecast, by End User
    • 7.4. Asia-Pacific

      • 7.4.1. Key market trends, growth factors and opportunities

      • 7.4.2. Market size and forecast, by Type

      • 7.4.3. Market size and forecast, by Application

      • 7.4.4. Market size and forecast, by End User

      • 7.4.5. Market size and forecast, by country

        • 7.4.5.1. China
          • 7.4.5.1.1. Market size and forecast, by Type
          • 7.4.5.1.2. Market size and forecast, by Application
          • 7.4.5.1.3. Market size and forecast, by End User
        • 7.4.5.2. Japan
          • 7.4.5.2.1. Market size and forecast, by Type
          • 7.4.5.2.2. Market size and forecast, by Application
          • 7.4.5.2.3. Market size and forecast, by End User
        • 7.4.5.3. India
          • 7.4.5.3.1. Market size and forecast, by Type
          • 7.4.5.3.2. Market size and forecast, by Application
          • 7.4.5.3.3. Market size and forecast, by End User
        • 7.4.5.4. South Korea
          • 7.4.5.4.1. Market size and forecast, by Type
          • 7.4.5.4.2. Market size and forecast, by Application
          • 7.4.5.4.3. Market size and forecast, by End User
        • 7.4.5.5. Australia
          • 7.4.5.5.1. Market size and forecast, by Type
          • 7.4.5.5.2. Market size and forecast, by Application
          • 7.4.5.5.3. Market size and forecast, by End User
        • 7.4.5.6. Rest of Asia-Pacific
          • 7.4.5.6.1. Market size and forecast, by Type
          • 7.4.5.6.2. Market size and forecast, by Application
          • 7.4.5.6.3. Market size and forecast, by End User
    • 7.5. LAMEA

      • 7.5.1. Key market trends, growth factors and opportunities

      • 7.5.2. Market size and forecast, by Type

      • 7.5.3. Market size and forecast, by Application

      • 7.5.4. Market size and forecast, by End User

      • 7.5.5. Market size and forecast, by country

        • 7.5.5.1. Brazil
          • 7.5.5.1.1. Market size and forecast, by Type
          • 7.5.5.1.2. Market size and forecast, by Application
          • 7.5.5.1.3. Market size and forecast, by End User
        • 7.5.5.2. Saudi Arabia
          • 7.5.5.2.1. Market size and forecast, by Type
          • 7.5.5.2.2. Market size and forecast, by Application
          • 7.5.5.2.3. Market size and forecast, by End User
        • 7.5.5.3. United Arab Emirates
          • 7.5.5.3.1. Market size and forecast, by Type
          • 7.5.5.3.2. Market size and forecast, by Application
          • 7.5.5.3.3. Market size and forecast, by End User
        • 7.5.5.4. South Africa
          • 7.5.5.4.1. Market size and forecast, by Type
          • 7.5.5.4.2. Market size and forecast, by Application
          • 7.5.5.4.3. Market size and forecast, by End User
        • 7.5.5.5. Rest of LAMEA
          • 7.5.5.5.1. Market size and forecast, by Type
          • 7.5.5.5.2. Market size and forecast, by Application
          • 7.5.5.5.3. Market size and forecast, by End User
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top winning strategies

    • 8.3. Product Mapping of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top player positioning, 2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Jungbunzlauer

      • 9.1.1. Company overview

      • 9.1.2. Key Executives

      • 9.1.3. Company snapshot

    • 9.2. Shandong Xinhong Pharmaceutical Co., Ltd.

      • 9.2.1. Company overview

      • 9.2.2. Key Executives

      • 9.2.3. Company snapshot

    • 9.3. Shandong Fuyuan Bio-Tech CO.LTD.

      • 9.3.1. Company overview

      • 9.3.2. Key Executives

      • 9.3.3. Company snapshot

    • 9.4. Merck Millipore Corporation

      • 9.4.1. Company overview

      • 9.4.2. Key Executives

      • 9.4.3. Company snapshot

    • 9.5. Shaoxing Marina Biotechnology Co.Ltd.

      • 9.5.1. Company overview

      • 9.5.2. Key Executives

      • 9.5.3. Company snapshot

    • 9.6. Shandong Baisheng Biotechnology Co., Ltd.

      • 9.6.1. Company overview

      • 9.6.2. Key Executives

      • 9.6.3. Company snapshot

    • 9.7. Roquette Freres

      • 9.7.1. Company overview

      • 9.7.2. Key Executives

      • 9.7.3. Company snapshot

    • 9.8. Functional Food chem International Corporation

      • 9.8.1. Company overview

      • 9.8.2. Key Executives

      • 9.8.3. Company snapshot

    • 9.9. Hubei Yitai Pharmaceutical Co.Ltd.

      • 9.9.1. Company overview

      • 9.9.2. Key Executives

      • 9.9.3. Company snapshot

    • 9.10. Anhui Fubore Pharmaceutical & Chemical Co.Ltd.

      • 9.10.1. Company overview

      • 9.10.2. Key Executives

      • 9.10.3. Company snapshot

  • LIST OF TABLES

  • TABLE 01. GLOBAL GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 02. GLUCURONOLACTONE MARKET FOR POWDER, BY REGION, 2022-2032 ($THOUSAND)
    TABLE 03. GLUCURONOLACTONE MARKET FOR LIQUID, BY REGION, 2022-2032 ($THOUSAND)
    TABLE 04. GLUCURONOLACTONE MARKET FOR TABLET/CAPSULE, BY REGION, 2022-2032 ($THOUSAND)
    TABLE 05. GLOBAL GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 06. GLUCURONOLACTONE MARKET FOR PRESERVATIVES, BY REGION, 2022-2032 ($THOUSAND)
    TABLE 07. GLUCURONOLACTONE MARKET FOR ANTIOXIDANTS, BY REGION, 2022-2032 ($THOUSAND)
    TABLE 08. GLUCURONOLACTONE MARKET FOR PROCESSING AIDS AND ADDITIVES, BY REGION, 2022-2032 ($THOUSAND)
    TABLE 09. GLUCURONOLACTONE MARKET FOR ENERGY SUPPLEMENTS, BY REGION, 2022-2032 ($THOUSAND)
    TABLE 10. GLOBAL GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 11. GLUCURONOLACTONE MARKET FOR FOOD AND BEVERAGES, BY REGION, 2022-2032 ($THOUSAND)
    TABLE 12. GLUCURONOLACTONE MARKET FOR PHARMACEUTICALS, BY REGION, 2022-2032 ($THOUSAND)
    TABLE 13. GLUCURONOLACTONE MARKET, BY REGION, 2022-2032 ($THOUSAND)
    TABLE 14. NORTH AMERICA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 15. NORTH AMERICA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 16. NORTH AMERICA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 17. NORTH AMERICA GLUCURONOLACTONE MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)
    TABLE 18. U.S. GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 19. U.S. GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 20. U.S. GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 21. CANADA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 22. CANADA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 23. CANADA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 24. MEXICO GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 25. MEXICO GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 26. MEXICO GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 27. EUROPE GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 28. EUROPE GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 29. EUROPE GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 30. EUROPE GLUCURONOLACTONE MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)
    TABLE 31. GERMANY GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 32. GERMANY GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 33. GERMANY GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 34. UK GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 35. UK GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 36. UK GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 37. FRANCE GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 38. FRANCE GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 39. FRANCE GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 40. SPAIN GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 41. SPAIN GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 42. SPAIN GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 43. ITALY GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 44. ITALY GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 45. ITALY GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 46. REST OF EUROPE GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 47. REST OF EUROPE GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 48. REST OF EUROPE GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 49. ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 50. ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 51. ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 52. ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)
    TABLE 53. CHINA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 54. CHINA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 55. CHINA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 56. JAPAN GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 57. JAPAN GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 58. JAPAN GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 59. INDIA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 60. INDIA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 61. INDIA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 62. SOUTH KOREA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 63. SOUTH KOREA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 64. SOUTH KOREA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 65. AUSTRALIA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 66. AUSTRALIA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 67. AUSTRALIA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 68. REST OF ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 69. REST OF ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 70. REST OF ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 71. LAMEA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 72. LAMEA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 73. LAMEA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 74. LAMEA GLUCURONOLACTONE MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)
    TABLE 75. BRAZIL GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 76. BRAZIL GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 77. BRAZIL GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 78. SAUDI ARABIA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 79. SAUDI ARABIA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 80. SAUDI ARABIA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 81. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 82. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 83. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 84. SOUTH AFRICA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 85. SOUTH AFRICA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 86. SOUTH AFRICA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 87. REST OF LAMEA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
    TABLE 88. REST OF LAMEA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
    TABLE 89. REST OF LAMEA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
    TABLE 90. JUNGBUNZLAUER: KEY EXECUTIVES
    TABLE 91. JUNGBUNZLAUER: COMPANY SNAPSHOT
    TABLE 92. SHANDONG XINHONG PHARMACEUTICAL CO., LTD.: KEY EXECUTIVES
    TABLE 93. SHANDONG XINHONG PHARMACEUTICAL CO., LTD.: COMPANY SNAPSHOT
    TABLE 94. SHANDONG FUYUAN BIO-TECH CO.LTD.: KEY EXECUTIVES
    TABLE 95. SHANDONG FUYUAN BIO-TECH CO.LTD.: COMPANY SNAPSHOT
    TABLE 96. MERCK MILLIPORE CORPORATION: KEY EXECUTIVES
    TABLE 97. MERCK MILLIPORE CORPORATION: COMPANY SNAPSHOT
    TABLE 98. SHAOXING MARINA BIOTECHNOLOGY CO.LTD.: KEY EXECUTIVES
    TABLE 99. SHAOXING MARINA BIOTECHNOLOGY CO.LTD.: COMPANY SNAPSHOT
    TABLE 100. SHANDONG BAISHENG BIOTECHNOLOGY CO., LTD.: KEY EXECUTIVES
    TABLE 101. SHANDONG BAISHENG BIOTECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
    TABLE 102. ROQUETTE FRERES: KEY EXECUTIVES
    TABLE 103. ROQUETTE FRERES: COMPANY SNAPSHOT
    TABLE 104. FUNCTIONAL FOOD CHEM INTERNATIONAL CORPORATION: KEY EXECUTIVES
    TABLE 105. FUNCTIONAL FOOD CHEM INTERNATIONAL CORPORATION: COMPANY SNAPSHOT
    TABLE 106. HUBEI YITAI PHARMACEUTICAL CO.LTD.: KEY EXECUTIVES
    TABLE 107. HUBEI YITAI PHARMACEUTICAL CO.LTD.: COMPANY SNAPSHOT
    TABLE 108. ANHUI FUBORE PHARMACEUTICAL & CHEMICAL CO.LTD.: KEY EXECUTIVES
    TABLE 109. ANHUI FUBORE PHARMACEUTICAL & CHEMICAL CO.LTD.: COMPANY SNAPSHOT
  • LIST OF FIGURES

  • FIGURE 01. GLUCURONOLACTONE MARKET, 2022-2032
    FIGURE 02. SEGMENTATION OF GLUCURONOLACTONE MARKET,2022-2032
    FIGURE 03. TOP INVESTMENT POCKETS IN GLUCURONOLACTONE MARKET (2023-2032)
    FIGURE 04. BARGAINING POWER OF SUPPLIERS
    FIGURE 05. BARGAINING POWER OF BUYERS
    FIGURE 06. THREAT OF SUBSTITUTION
    FIGURE 07. THREAT OF SUBSTITUTION
    FIGURE 08. COMPETITIVE RIVALRY
    FIGURE 09. GLOBAL GLUCURONOLACTONE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 10. REGULATORY GUIDELINES: GLUCURONOLACTONE MARKET
    FIGURE 11. IMPACT OF KEY REGULATION: GLUCURONOLACTONE MARKET
    FIGURE 12. PATENT ANALYSIS BY COMPANY
    FIGURE 13. PATENT ANALYSIS BY COUNTRY
    FIGURE 14. GLUCURONOLACTONE MARKET, BY TYPE, 2022 AND 2032(%)
    FIGURE 15. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR POWDER, BY COUNTRY 2022 AND 2032(%)
    FIGURE 16. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR LIQUID, BY COUNTRY 2022 AND 2032(%)
    FIGURE 17. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR TABLET/CAPSULE, BY COUNTRY 2022 AND 2032(%)
    FIGURE 18. GLUCURONOLACTONE MARKET, BY APPLICATION, 2022 AND 2032(%)
    FIGURE 19. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR PRESERVATIVES, BY COUNTRY 2022 AND 2032(%)
    FIGURE 20. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR ANTIOXIDANTS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 21. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR PROCESSING AIDS AND ADDITIVES, BY COUNTRY 2022 AND 2032(%)
    FIGURE 22. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR ENERGY SUPPLEMENTS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 23. GLUCURONOLACTONE MARKET, BY END USER, 2022 AND 2032(%)
    FIGURE 24. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR FOOD AND BEVERAGES, BY COUNTRY 2022 AND 2032(%)
    FIGURE 25. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR PHARMACEUTICALS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 26. GLUCURONOLACTONE MARKET BY REGION, 2022 AND 2032(%)
    FIGURE 27. U.S. GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
    FIGURE 28. CANADA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
    FIGURE 29. MEXICO GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
    FIGURE 30. GERMANY GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
    FIGURE 31. UK GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
    FIGURE 32. FRANCE GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
    FIGURE 33. SPAIN GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
    FIGURE 34. ITALY GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
    FIGURE 35. REST OF EUROPE GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
    FIGURE 36. CHINA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
    FIGURE 37. JAPAN GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
    FIGURE 38. INDIA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
    FIGURE 39. SOUTH KOREA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
    FIGURE 40. AUSTRALIA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
    FIGURE 41. REST OF ASIA-PACIFIC GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
    FIGURE 42. BRAZIL GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
    FIGURE 43. SAUDI ARABIA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
    FIGURE 44. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
    FIGURE 45. SOUTH AFRICA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
    FIGURE 46. REST OF LAMEA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
    FIGURE 47. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 50. PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 51. COMPETITIVE DASHBOARD
    FIGURE 52. COMPETITIVE HEATMAP: GLUCURONOLACTONE MARKET
    FIGURE 53. TOP PLAYER POSITIONING, 2022

Purchase Full Report of
Glucuronolactone Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue